gsk glp 1 agonist GLP-1 Receptor Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways Frontiers | Unlocking the potential
Description
[DOI] [PubMed] [Google Scholar] 9.Killion EA, Wang J, Yie J, Shi SD, Bates D, Min X, et al
Graham, D
Recently, a surfactant conjugated co-agonist peptide 17 was shown to have a half-life of 52 hours in vivo and at a higher dose led to 40% body weight loss in obese rats over 27 days (79)
2024;47(Suppl 1):S15878
Suppose you are struggling with weight loss or have concerns related to obesity or its associated health risks
